Hybrid Farm

Hybrid Farm is a South Korean biotechnology company specializing in the development of advanced drug delivery systems through its proprietary hybrid exosome platform. The company's core technology, HybriSome, integrates natural exosomes with synthetic lipids to create highly stable and efficient delivery vehicles for various therapeutic cargoes, including mRNA, siRNA, and small molecules. Hybrid Farm focuses on addressing unmet medical needs in oncology and inflammatory diseases by improving the targeting and safety profiles of systemic treatments. By combining the biocompatibility of biological vesicles with the engineering flexibility of synthetic nanoparticles, the company aims to overcome the traditional limitations of current delivery technologies.